StockNews.com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)

StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research note published on Tuesday morning. The brokerage issued a sell rating on the stock. A number of other analysts also recently issued reports on ONCT. HC Wainwright downgraded shares of Oncternal Therapeutics from a buy rating to a neutral rating […]

Related Keywords

San Diego ,California ,United States ,Jamesb Breitmeyer ,Davidf Hale , ,Renaissance Technologies ,Maxim Group ,Healthcare Of Ontario Pension Plan Trust Fund ,Oncternal Therapeutics Inc ,Cantor Fitzgerald ,Waypoint Capital Advisors ,Oncternal Therapeutics Company Profile ,Oncternal Therapeutics ,Get Rating ,Capital Management ,Capital Advisors ,Ontario Pension Plan Trust Fund ,Sigma Investments ,Two Sigma Advisers ,Sigma Advisers ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,